Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new revision entry v3.3.3 to the Study Record Versions history; removed the items HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page history shows an added Revision: v3.3.2 and removal of Revision: v3.2.0, which are metadata updates to the record history and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe record history now includes a new version (16) posted on 2025-11-12 and adds sections for Outcome Measures and Study Status.SummaryDifference1%

- Check69 days agoChange DetectedNew record version (v15) has been added to the history, showing an updated Recruitment Status and Study Status.SummaryDifference0.1%

- Check91 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

- Check98 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.